Michael Earl, director, Pharmaceutical Services at Owen Mumford, explains how Owen Mumford’s Covid-compliant study design and careful planning allowed them to finalise their product design and present this innovative product to the market. The platform disposable auto-injector, Aidaptus, is designed to address the priorities of both patients and pharmaceutical manufacturers.
Key highlights:
- OM's Aidaptus introduces a consistent injection process for users. The injection process has two phases, where needle insertion and dose delivery are controlled by two separate springs.
- The Aidaptus’ design keeps the needle hidden before, during and after use; this feature can help to make injection less intimidating and may encourage treatment adherence as a result.
- Aidaptus’ design aims to provide pharma manufacturers the option to modify drug volumes and viscosities, without needing to change their selected delivery device.
Facilitating the injection process